Matriptase-2 deficiency protects from obesity by modulating iron homeostasis
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Alterations in iron status have frequently been associated with obesity and other metabolic disorders. The hormone hepcidin stands out as a key regulator in the maintenance of iron homeostasis by controlling the main iron exporter, ferroportin. Here we demonstrate that the deficiency in the hepcidin repressor matriptase-2 (Tmprss6) protects from high-fat diet-induced obesity. Tmprss6 −/− mice show a significant decrease in body fat, improved glucose tolerance and insulin sensitivity, and are protected against hepatic steatosis. Moreover, these mice exhibit a significant increase in fat lipolysis, consistent with their dramatic reduction in adiposity. Rescue experiments that block hepcidin up-regulation and restore iron levels in Tmprss6−/− mice via anti-hemojuvelin (HJV) therapy, revert the obesity-resistant phenotype of Tmprss6−/− mice. Overall, this study describes a role for matritpase-2 and hepcidin in obesity and highlights the relevance of iron regulation in the control of adipose tissue function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
Finberg, K. E., Heeney, M. M., Campagna, D. R., Aydınok, Y., Pearson, H. A., Hartman, K. R., Mayo, M. M., Samuel, S. M., Strouse, J. J., Markianos, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.130 · Cited by 675
The serine protease TMPRSS6 is required to sense iron deficiency
Du, X., She, E., Gelbart, T., Truksa, J., Lee, P., Xia, Y., Khovananth, K., Mudd, S., Mann, N., Moresco, E. M. Y., et al. (2008) · Science · doi:10.1126/science.1157121 · Cited by 578
Bekri, S., Gual, P., Anty, R., Luciani, N., Dahman, M., Ramesh, B., Iannelli, A., Staccini–Myx, A., Casanova, D., Ben Amor, I., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.007 · Cited by 496
Kautz, L., Meynard, D., Monnier, A., Darnaud, V., Bouvet, R., Wang, R.-H., Deng, C., Vaulont, S., Mosser, J., Coppin, H., et al. (2008) · Blood · doi:10.1182/blood-2008-03-143354 · Cited by 437
Inflammation and iron deficiency in the hypoferremia of obesity
Yanoff, L. B., Menzie, C. M., Denkinger, B., Sebring, N. G., McHugh, T., Remaley, A. T., & Yanovski, J. A. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803625 · Cited by 341
Iron homeostasis in the metabolic syndrome
Datz, C., Felder, T. K., Niederseer, D., & Aigner, E. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12032 · Cited by 181
A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia
Guida, C., Altamura, S., Klein, F. A., Galy, B., Boutros, M., Ulmer, A. J., Hentze, M. W., & Muckenthaler, M. U. (2015) · Blood · doi:10.1182/blood-2014-08-595256 · Cited by 173
Research works printed but not linked: 31
- Theurl, I. et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 113, 5277–5286 (2009). · DOI · Paper page
- Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090–2093 (2004). · DOI · Paper page
- Dongiovanni, P. et al. Dietary iron overload induces visceral adipose tissue insulin resistance. Am. J. Pathol. 182, 2254–2263 (2013). · DOI · Paper page
- Gabrielsen, J. S. et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J. Clin. Invest 122, 3529–3540 (2012). · DOI · Paper page
- Gao, Y. et al. Adipocyte iron regulates leptin and food intake. J. Clin. Invest 125, 3681–3691 (2015). · DOI · Paper page
- Folgueras, A. R. et al. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 112, 2539–2545 (2008). · DOI · Paper page
- Willemetz, A. et al. Matriptase-2 is essential for hepcidin repression during fetal life and postnatal development in mice to maintain iron homeostasis. Blood 124, 441–444 (2014). · DOI
- Ramsay, A. J., Hooper, J. D., Folgueras, A. R., Velasco, G. & Lopez-Otin, C. Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 94, 840–849 (2009). · DOI
- Wang, C. Y., Meynard, D. & Lin, H. Y. The role of TMPRSS6/matriptase-2 in iron regulation and anemia. Front Pharmacol. 5, 114 (2014).
- Lenoir, A. et al. Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6. Blood 117, 647–650 (2011). · DOI · Paper page
- Ramsay, A. J. et al. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms. Hum. Mol. Genet. 18, 3673–3683 (2009). · DOI · Paper page
- De Falco, L. et al. Iron refractory iron deficiency anemia. Haematologica 98, 845–853 (2013). · DOI · Paper page
- Heeney, M. M. & Finberg, K. E. Iron-refractory iron deficiency anemia (IRIDA). Hematol. Oncol. Clin. North Am. 28, 637–652 (2014). · DOI
- Daba, A., Gkouvatsos, K., Sebastiani, G. & Pantopoulos, K. Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: compartmentalization is critical for iron sensing. J. Mol. Med. 91, 95–102 (2013). · DOI
- Matsusue, K. et al. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab. 7, 302–311 (2008). · DOI · Paper page
- Mottillo, E. P., Shen, X. J. & Granneman, J. G. Role of hormone-sensitive lipase in beta-adrenergic remodeling of white adipose tissue. Am. J. Physiol. Endocrinol. Metab. 293, E1188–E1197 (2007). · DOI · Paper page
- Kraemer, F. B. & Shen, W. J. Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis. J. Lipid Res. 43, 1585–1594 (2002). · DOI · Paper page
- Martinelli, N. et al. Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. PLoS ONE 7, e48250 (2012). · DOI · Paper page
- Barisani, D. et al. Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload. J. Hepatol. 49, 123–133 (2008). · DOI
- Bridle, K. R. et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669–673 (2003). · DOI · Paper page
- Powell, E. E. et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 129, 1937–1943 (2005). · DOI · Paper page
- Bonkovsky, H. L. et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J. Hepatol. 31, 421–429 (1999). · DOI · Paper page
- Tan, T. C. et al. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G865–G876 (2011). · DOI
- Lu, S., Bennett, R. G., Kharbanda, K. K. & Harrison-Findik, D. D. Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver. World J. Hepatol. 8, 211–225 (2016). · DOI
- Finberg, K. E., Whittlesey, R. L., Fleming, M. D. & Andrews, N. C. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood 115, 3817–3826 (2010). · DOI · Paper page
- Kovac, S. et al. Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels. Haematologica 101, e173–e176 (2016). · DOI · Paper page
- Cooksey, R. C. et al. Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am. J. Physiol. Endocrinol. Metab. 298, E1236–E1243 (2010). · DOI · Paper page
- Patil, M. et al. Id1 Promotes obesity by suppressing brown adipose thermogenesis and white adipose browning. Diabetes 66, 1611–1625 (2017). · DOI
- Satyanarayana, A., Klarmann, K. D., Gavrilova, O. & Keller, J. R. Ablation of the transcriptional regulator Id1 enhances energy expenditure, increases insulin sensitivity, and protects against age and diet induced insulin resistance, and hepatosteatosis. FASEB J. 26, 309–323 (2012). · DOI
- Cutchins, A. et al. Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion. Arterioscler. Thromb. Vasc. Biol. 32, 317–324 (2012). · DOI
- Murad, J. M. et al. Inhibitor of DNA binding 4 (ID4) regulation of adipocyte differentiation and adipose tissue formation in mice. J. Biol. Chem. 285, 24164–24173 (2010). · DOI
Cited by
Iron metabolism and iron disorders revisited in the hepcidin era
Camaschella, C., Nai, A., & Silvestri, L. (2020) · Haematologica · doi:10.3324/haematol.2019.232124 · Cited by 734
Ferroptosis in liver disease: new insights into disease mechanisms
Wu, J., Wang, Y., Jiang, R., Xue, R., Yin, X., Wu, M., & Meng, Q. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00660-4 · Cited by 281
Iron Metabolism in Obesity and Metabolic Syndrome
González-Domínguez, Á., Visiedo-García, F. M., Domínguez-Riscart, J., González-Domínguez, R., Mateos, R. M., & Lechuga-Sancho, A. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155529 · Cited by 227
Management versus miscues in the cytosolic labile iron pool: The varied functions of iron chaperones
Philpott, C. C., Patel, S. J., & Protchenko, O. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118830 · Cited by 105
“Mouse studies also demonstrate that excess liver iron contributes to oxidative stress, steatosis, and liver damage (Folgueras et al., 2018; Handa et al., 2016).”
Background
Metadata
- Authors
- Folgueras, A. R., Freitas-Rodríguez, S., Ramsay, A. J., Garabaya, C., Rodríguez, F., Velasco, G., & López-Otín, C.
- Venue
- Nature Communications
- Published
- 2018-04-10
- Volume
- 9
- Issue
- 1
- Pages
- 1350-1350
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2797532322
- Cited by
- 49
- References
- 10
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Matriptase-2 deficiency protects from obesity by modulating iron homeostasis. https://app.cochat.ai/papers/10.1038/s41467-018-03853-1
- The paper
- Folgueras, A. R., Freitas-Rodríguez, S., Ramsay, A. J., Garabaya, C., Rodríguez, F., Velasco, G., & López-Otín, C. (2018). Matriptase-2 deficiency protects from obesity by modulating iron homeostasis. Nature Communications. https://doi.org/10.1038/s41467-018-03853-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.